Concepts (59)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Appendiceal Neoplasms | 1 | 2020 | 9 | 0.770 |
Why?
|
| Carcinoid Tumor | 1 | 2020 | 20 | 0.770 |
Why?
|
| Appendectomy | 1 | 2020 | 47 | 0.750 |
Why?
|
| Emergencies | 1 | 2020 | 107 | 0.740 |
Why?
|
| Colectomy | 1 | 2020 | 64 | 0.740 |
Why?
|
| Wounds and Injuries | 2 | 2021 | 334 | 0.290 |
Why?
|
| Central Venous Catheters | 1 | 2022 | 19 | 0.220 |
Why?
|
| Catheterization, Central Venous | 1 | 2022 | 89 | 0.210 |
Why?
|
| Traumatology | 1 | 2021 | 20 | 0.210 |
Why?
|
| Intracranial Pressure | 1 | 2021 | 58 | 0.200 |
Why?
|
| Coagulants | 1 | 2021 | 4 | 0.200 |
Why?
|
| Prosthesis Implantation | 1 | 2021 | 83 | 0.190 |
Why?
|
| Factor Xa Inhibitors | 1 | 2021 | 43 | 0.190 |
Why?
|
| Surgeons | 1 | 2021 | 68 | 0.190 |
Why?
|
| Monitoring, Physiologic | 1 | 2021 | 219 | 0.190 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2021 | 105 | 0.180 |
Why?
|
| Thrombelastography | 1 | 2019 | 19 | 0.180 |
Why?
|
| Point-of-Care Testing | 1 | 2019 | 12 | 0.180 |
Why?
|
| Hemorrhage | 1 | 2021 | 328 | 0.170 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 298 | 0.150 |
Why?
|
| Anticoagulants | 1 | 2019 | 356 | 0.140 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 498 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2021 | 2323 | 0.120 |
Why?
|
| Injury Severity Score | 2 | 2021 | 204 | 0.100 |
Why?
|
| Brenner Tumor | 1 | 2009 | 1 | 0.090 |
Why?
|
| Middle Aged | 3 | 2021 | 21119 | 0.080 |
Why?
|
| Ovarian Neoplasms | 1 | 2009 | 267 | 0.080 |
Why?
|
| Female | 5 | 2021 | 38015 | 0.080 |
Why?
|
| Humans | 7 | 2022 | 68525 | 0.070 |
Why?
|
| Adult | 5 | 2022 | 21375 | 0.070 |
Why?
|
| Thorax | 1 | 2022 | 49 | 0.060 |
Why?
|
| Vena Cava, Superior | 1 | 2022 | 41 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2021 | 3702 | 0.050 |
Why?
|
| Historically Controlled Study | 1 | 2021 | 7 | 0.050 |
Why?
|
| APACHE | 1 | 2021 | 41 | 0.050 |
Why?
|
| Glasgow Coma Scale | 1 | 2021 | 65 | 0.050 |
Why?
|
| Narcotics | 1 | 2022 | 65 | 0.050 |
Why?
|
| Neurosurgeons | 1 | 2021 | 22 | 0.050 |
Why?
|
| Safety | 1 | 2021 | 145 | 0.050 |
Why?
|
| Factor Xa | 1 | 2021 | 10 | 0.050 |
Why?
|
| Blood Coagulation Factors | 1 | 2021 | 44 | 0.050 |
Why?
|
| Time-to-Treatment | 1 | 2021 | 117 | 0.050 |
Why?
|
| Inpatients | 1 | 2022 | 208 | 0.050 |
Why?
|
| Pain Management | 1 | 2022 | 186 | 0.050 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 151 | 0.050 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 214 | 0.040 |
Why?
|
| Trauma Centers | 1 | 2021 | 197 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2022 | 7264 | 0.040 |
Why?
|
| Male | 4 | 2022 | 37281 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2021 | 742 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 472 | 0.040 |
Why?
|
| Survival Rate | 1 | 2021 | 1055 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1548 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 1753 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 4843 | 0.020 |
Why?
|
| Aged | 2 | 2021 | 14842 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2021 | 7028 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 5708 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 8903 | 0.020 |
Why?
|